Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Dec 17, 2018 12:24PM

Dec 17, 2018 12:32PM

Dec 26, 2018 04:40PM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Biotech Showcase

in response to

Re: Biotech Showcase

noretreat

posted on Jan 08, 2019 11:15AM

Noretreat,

Thanks in advance for letting us know you will be attending Biotech Showcase. We look forward to any info you may share with us about both the Resverlogix presentation yesterday and the Zenith presentation today (9:15 AM Pacific). Good luck to Zenith!